The American fund holds 51% of the capital of the new company, to which Santander will transfer €30,000 million in toxic assets. Santander controls the remaining 49%, according to El Confidencial.
Metrovacesa will quote on the stock exchange next year, with assets valued at around €2,600 million. The General Meeting of Shareholders votes the decision on December 19.